$24.36
0.351.46%
al cierre: -
$24.50
0.140.57%
After hour: Apr 14, 7:00 AM EDT
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH)
Ticker | Name | Share % | |
---|---|---|---|
PFE | Pfizer, Inc. | 7.13% | |
ABBV | Abbvie Inc. | 7.58% | |
JNJ | Johnson & Johnson | 7.13% | |
BMY | Bristol-Myers Squibb Co. | 7.67% | |
MRK | Merck & Company, Inc. | 7.25% | |
UTHR | United Therapeutic | 3.68% | |
AMGN | Amgen Inc. | 3.83% | |
VRTX | Nvaesrtex Pharmaceuticals Inc | 4.02% | |
REGN | Regeneron Parmaceuticals Inc. | 3.93% | |
GILD | Gilead Sciences Inc | 3.74% | |
CAH | Cardinal Health Inc. | 4.32% | |
JAZZ | Jazz Pharmaceuticals Plc | 3.95% | |
LLY | Eli Lilly & Co. | 3.60% | |
ZTS | Zoetis Inc . | 3.72% | |
BIIB | Biogen Inc. Com | 3.61% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
FTXH sigue un estilo de inversión Large Cap Blend.
Las principales posiciones de FTXH incluyen: PFE (7.13%), ABBV (7.58%), JNJ (7.13%), BMY (7.67%), MRK (7.25%). Estas representan las mayores posiciones en la cartera del ETF.
Los datos del volumen medio diario para FTXH no están disponibles actualmente.